 |
 |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 Featured MNV Articles:
| Analysts See 10% Gains Ahead For The Holdings of QVMSBy Dividend Channel Staff, Monday, January 8, 9:21 AM ET
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco S&P SmallCap 600 QVM Multi-factor ETF (NYSE:QVMS), we found that the implied analyst target price for the ETF based upon its underlying holdings is $26.41 per unit. With QVMS trading at a recent price near $24.08 per unit, that means that analysts see 9.69% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of QVMS's underlying holdings with notable upside to their analyst target prices are Gentherm Inc (NASDAQ:THRM), Viad Corp. (NYSE:VVI), and Healthcare Services Group, Inc. (NASDAQ:HCSG). Although THRM has traded at a recent price of $49.14/share, the average analyst target is 31.05% higher at $64.40/share. Similarly, VVI has 26.84% upside from the recent share price of $33.90 if the average analyst target price of $43.00/share is reached, and analysts on average are expecting HCSG to reach a target price of $12.75/share, which is 26.74% above the recent price of $10.06. Below is a twelve month price history chart comparing the stock performance of THRM, VVI, and HCSG:
Below is a summary table of the current analyst target prices discussed above:
Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research. The average analyst target price data upon which this article was based, is courtesy of data provided by Zacks Investment Research via Quandl.com.
This Article's Word Cloud:
Analyst
Below
Corp
ETFs
FREEGet
Gentherm
Group
HCSG
Healthcare
Invesco
Multi
NYSE
QVMS
Services
SmallCap
THRM
Target
Upside
Viad
With
Zacks
about
above
analyst
analysts
average
background
based
border
bottom
color
data
factor
font
from
hctblstyle
holdings
latest
mdash
price
recent
report
research
share
target
targets
that
trading
underlying
upside
|
Play Video:
The Importance of ETFs
Free Email Alerts By Stock:
Start slideshow: